About the Authors
Institute of Healthy Ageing, and Research Department of Genetics, Evolution and Environment, University College London, London, United Kingdom
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York, United States of America
Boyce Thompson Institute and Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York, United States of America
Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut, United States of America
Department of Biology, Ghent University, Ghent, Belgium
Institute of Molecular Biology and Biotechnology, University of Crete, Heraklion, Crete, Greece
Department of Medicine, University of Rochester Medical Center, Rochester, New York, United States of America
The authors have declared that no competing interests exist.
The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: CC DG KN PM AB FC. Performed the experiments: CC AD SAE AS FS ZP PM BB FM AM GF EA KN MV NT AB CA FC REP. Analyzed the data: CC DG KN EA PM FS BB FM MV NT AB. Contributed reagents/materials/analysis tools: PM FS EA FJS KN FM BB. Wrote the paper: CC DG KN. AS worked as an undergraduate project student to identify the severity of different Glo mutant phenotypes, consequently allowing us to select glo-1(zu347) as the primary mutant of study.